Michael Friedman
Pasadena, CANPI 1275900623
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $723,081 of the $777,579 with a category attached, or 93.0%. Bristol Myers Squibb accounts for 70.7% of it on its own, with 3 other manufacturers making up the rest.
Across 89 payments — averaging $8736.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$550K
- Smith+Nephew$98K
- Intuitive Surgical$71K
- Mannkind Corporation$59K
What the payments were for
- Speaking & faculty fees$723,08193%
- Travel & lodging$49,4606%
- Food & beverage$2,8860%
- Gifts$2,1520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 36 | $549,925 |
| Smith+Nephew | 35 | $97,905 |
| Intuitive Surgical | 6 | $70,912 |
| Mannkind Corporation | 12 | $58,836 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$70,912
- AFREZZA$58,836
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.